companiesSEC EDGAR
BlossomHill Therapeutics, Inc.

SEC EDGAR published this disclosure on 2026-09-18. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001193125-26-395043
cik1839970
company nameBlossomHill Therapeutics, Inc.
form10-Q